219 related articles for article (PubMed ID: 27572905)
1. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
[TBL] [Abstract][Full Text] [Related]
4. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
[TBL] [Abstract][Full Text] [Related]
6. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
7. TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk.
Chen Y; Shi C; Guo Q
World J Surg Oncol; 2016 Feb; 14(1):50. PubMed ID: 26911390
[TBL] [Abstract][Full Text] [Related]
8. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer genome-wide association studies: there is strength in numbers.
Fanale D; Amodeo V; Corsini LR; Rizzo S; Bazan V; Russo A
Oncogene; 2012 Apr; 31(17):2121-8. PubMed ID: 21996731
[TBL] [Abstract][Full Text] [Related]
10. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
[TBL] [Abstract][Full Text] [Related]
12. Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.
Campa D; Kaaks R; Le Marchand L; Haiman CA; Travis RC; Berg CD; Buring JE; Chanock SJ; Diver WR; Dostal L; Fournier A; Hankinson SE; Henderson BE; Hoover RN; Isaacs C; Johansson M; Kolonel LN; Kraft P; Lee IM; McCarty CA; Overvad K; Panico S; Peeters PH; Riboli E; Sanchez MJ; Schumacher FR; Skeie G; Stram DO; Thun MJ; Trichopoulos D; Zhang S; Ziegler RG; Hunter DJ; Lindström S; Canzian F
J Natl Cancer Inst; 2011 Aug; 103(16):1252-63. PubMed ID: 21791674
[TBL] [Abstract][Full Text] [Related]
13. Predictive accuracy of the breast cancer genetic risk model based on eight common genetic variants: The BACkSIDE study.
Danková Z; Žúbor P; Grendár M; Zelinová K; Jagelková M; Stastny I; Kapinová A; Vargová D; Kasajová P; Dvorská D; Kalman M; Danko J; Lasabová Z
J Biotechnol; 2019 Jun; 299():1-7. PubMed ID: 31002855
[TBL] [Abstract][Full Text] [Related]
14. Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women.
Gorodnova TV; Kuligina ESh; Yanus GA; Katanugina AS; Abysheva SN; Togo AV; Imyanitov EN
Cancer Genet Cytogenet; 2010 May; 199(1):69-72. PubMed ID: 20417875
[No Abstract] [Full Text] [Related]
15. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
16. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Antoniou AC; Spurdle AB; Sinilnikova OM; Healey S; Pooley KA; Schmutzler RK; Versmold B; Engel C; Meindl A; Arnold N; Hofmann W; Sutter C; Niederacher D; Deissler H; Caldes T; Kämpjärvi K; Nevanlinna H; Simard J; Beesley J; Chen X; ; Neuhausen SL; Rebbeck TR; Wagner T; Lynch HT; Isaacs C; Weitzel J; Ganz PA; Daly MB; Tomlinson G; Olopade OI; Blum JL; Couch FJ; Peterlongo P; Manoukian S; Barile M; Radice P; Szabo CI; Pereira LH; Greene MH; Rennert G; Lejbkowicz F; Barnett-Griness O; Andrulis IL; Ozcelik H; ; Gerdes AM; Caligo MA; Laitman Y; Kaufman B; Milgrom R; Friedman E; ; Domchek SM; Nathanson KL; Osorio A; Llort G; Milne RL; Benítez J; Hamann U; Hogervorst FB; Manders P; Ligtenberg MJ; van den Ouweland AM; ; Peock S; Cook M; Platte R; Evans DG; Eeles R; Pichert G; Chu C; Eccles D; Davidson R; Douglas F; ; Godwin AK; Barjhoux L; Mazoyer S; Sobol H; Bourdon V; Eisinger F; Chompret A; Capoulade C; Bressac-de Paillerets B; Lenoir GM; Gauthier-Villars M; Houdayer C; Stoppa-Lyonnet D; ; Chenevix-Trench G; Easton DF;
Am J Hum Genet; 2008 Apr; 82(4):937-48. PubMed ID: 18355772
[TBL] [Abstract][Full Text] [Related]
17. Low-risk variants FGFR2, TNRC9 and LSP1 in German familial breast cancer patients.
Hemminki K; Müller-Myhsok B; Lichtner P; Engel C; Chen B; Burwinkel B; Försti A; Sutter C; Wappenschmidt B; Hellebrand H; Illig T; Arnold N; Niederacher D; Dworniczak B; Deissler H; Kast K; Gadzicki D; Meitinger T; Wichmann HE; Kiechle M; Bartram CR; Schmutzler RK; Meindl A
Int J Cancer; 2010 Jun; 126(12):2858-62. PubMed ID: 19856316
[TBL] [Abstract][Full Text] [Related]
18. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
[TBL] [Abstract][Full Text] [Related]
19. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of the effect of FGFR2 gene polymorphism on the risk of breast cancer.
Jia C; Cai Y; Ma Y; Fu D
Breast Cancer Res Treat; 2010 Nov; 124(2):521-8. PubMed ID: 20364400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
